Holen Sie sich die Stockscreener-App
38.27
0.89%
0.245
Eton Pharmaceuticals Inc Aktie (ETON) Neueste Nachrichten
Eton Pharmaceuticals stock hits all-time high at 38.6 USD By Investing.com - Investing.com Canada
Precision Trading with Eton Pharmaceuticals Inc. (ETON) Risk Zones - Stock Traders Daily
Enterprise value to revenue forward of Eton Pharmaceuticals, Inc. – NASDAQ:ETON - TradingView
Form 4 Eton Pharmaceuticals Inc For: 30 June By Investing.com - Investing.com Nigeria
Eton Pharmaceuticals (ETON) CBO awarded 10,000 restricted stock units - Stock Titan
Eton Pharmaceuticals stock hits all-time high at 36.97 USD - Investing.com
Eton Pharmaceuticals stock hits all-time high at 36.97 USD By Investing.com - Investing.com India
Enterprise value to revenue forward of Eton Pharmaceuticals, Inc. – BOATS:ETON - TradingView
Price to sales forward of Eton Pharmaceuticals, Inc. – NASDAQ:ETON - TradingView
Price to book forward of Eton Pharmaceuticals, Inc. – BOATS:ETON - TradingView
Enterprise value to EBIT forward of Eton Pharmaceuticals, Inc. – NASDAQ:ETON - TradingView
Price to sales forward of Eton Pharmaceuticals, Inc. – BOATS:ETON - TradingView
Enterprise value to EBITDA forward of Eton Pharmaceuticals, Inc. – BOATS:ETON - TradingView
Form 144 Eton Pharmaceuticals For: 26 June By Investing.com - Investing.com Australia
ETON (ETON) Form 144: Affiliate sales include 25,000-share disposals - Stock Titan
Eton Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:ETON) - TradingView
ETON Forecast — Price Target — Prediction for 2027 - TradingView
Form 144 Eton Pharmaceuticals For: 25 June By Investing.com - Investing.com Nigeria
ETON (NASDAQ: ETON) notice: Director proposes sale of 25,000 shares - Stock Titan
Eton Pharmaceuticals, Inc. (ETON) misses Q1 earnings estimates - MSN
Eton Pharmaceuticals (ETON) Gains 2.5% as Bullish Momentum StrengthensMoving Average Ribbon - dars.gov.et
Eton Pharmaceuticals Inc (ETON) Institutional Confidence - TradingKey
Eton Pharmaceuticals Inc (ETON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Form 144 Eton Pharmaceuticals For: 23 June By Investing.com - Investing.com South Africa
Insider files to sell 25,000 shares via option exercise | ETON SEC FilingForm 144 - Stock Titan
Eton Pharmaceuticals, Inc.(NasdaqGM:ETON) added to S&P Pharmaceuticals Select Industry Index - marketscreener.com
Eton Pharmaceuticals StockLong-term strategy in rare disease drugs - Ad-hoc-news.de
Eton Pharmaceuticals director Adams sells 50,000 shares for $1.62m By Investing.com - Investing.com India
Eton Pharmaceuticals director Adams sells 50,000 shares for $1.62m - Investing.com UK
Eton Pharmaceuticals Insider Sold Shares Worth $1,623,795, According to a Recent SEC Filing - marketscreener.com
Eton Pharmaceuticals Director Sold Shares Worth Over $1.6M - TradingView
Eton Pharmaceuticals (ETON) director exercises options, sells 50,000 shares in open market - Stock Titan
[144] Eton Pharmaceuticals, Inc. SEC Filing - Stock Titan
Eton Pharmaceuticals Inc (ETON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Eton Pharmaceuticals Inc (ETON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ETON Stock Price, Quote & Chart - ChartMill
Eton Pharmaceuticals (ETON) surges 19.8%: Is this an indication of further gains? - MSN
Eton Pharmaceuticals (ETON) Surges 4.75% as Momentum Builds Toward ResistanceWatchlist Stock Ideas - newsline.com
Trading the Move, Not the Narrative: (ETON) Edition - Stock Traders Daily
Eton Pharmaceuticals (NASDAQ: ETON) 2026 vote supports board and auditor - Stock Titan
Eton Pharmaceuticals (ETON) Gains 2.8% as Bullish Momentum Builds Toward ResistanceHigh Beta Stocks - newsline.com
Eton Pharmaceuticals Rallies as Stock Approaches Key Resistance (ETON)Total Put Call - newsline.com
Eton Pharmaceuticals (ETON) Holds Steady Near Resistance With Modest GainDividend ETF - newsline.com
ETON Q1 2026 Earnings: EPS Misses Estimates Despite Narrow ProfitCore Business Growth - newsline.com
Possible Bearish Signals With Eton Pharmaceuticals Insiders Disposing Stock - simplywall.st
ETON: Aggressively scaling rare disease portfolio with strong sales, margin growth, and patient focus - TradingView
0.17%
1.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):